Zyn, nicotine pouches and FDA

FDA makes key decision on Zyn nicotine pouches
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.
What are Zyn nicotine pouches? And are they bad for you?
The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, especially for young people, and experts say there's little evidence that they help adults quit smoking.
Zyn nicotine pouches get FDA approval
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
FDA 'Closely Monitoring' Zyn Nicotine Pouches After Marketing Approval
The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but will be "closely monitoring youth use." Newsweek reached out to Zyn for comment.
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.
FDA officially authorizes Zyn nicotine pouches for sale following health review
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.
Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
FDA approves sale of Zyn nicotine pouches following extensive review
The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs. cigarettes and other tobacco products. It is the first time the agency has authorized the sale of nicotine pouches,
FDA Allows Flavored Zyn Nicotine Pouches to Stay on the Market
The agency found Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.
US FDA grants first market authorization of nicotine pouches to Zyn
The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...
WHYY3d
FDA regulation of nicotine pouches can help prevent youth use, say Rutgers researchers
Nicotine pouches are a newer class of smokeless products that don’t contain tobacco. Zyn became the first FDA-authorized ...
Let Freedom Zyn
Let freedom ryng: On Thursday, the Food and Drug Administration (FDA) authorized the marketing of 20 Zyn nicotine pouch ...